Applications published 28 February 2007
 Pyrrolobenzodiazepine therapeutic agents useful in the treatment of leukaemias
Spirogen    1755612*
 Substituted cyclic urea derivatives
Bayer CropScience    1755613*
 Compsns and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
Vela Pharmaceuticals    1755614*
 Supportive treatment of liver disease
Howard J Smith and Associates Pty    1755615*
 Treatment of ophthalmic conditions with mineral corticoids
Advanced Ocular Systems    1755616*
 Perfluorocarbon-soluble compounds
University of Southern California    1755617*
 Compsns and methods for treatment of premenstrual disorder
Wyeth    1755618*
 Anti-adhesive compounds to prevent and treat bacterial infections
VIB; Vrije Universiteit Brussel    1755619*
 Sulphated depolymerised exopolysaccharide derivatives, their preparation and use
Institut Francais de Recherche pour l'Exploitation de la Mer; Universite Rene Descartes    1755620*
 Method of treating hepatocellular carcinoma with denspm
Genzyme; University of Florida Research Foundation    1755621*
 Treatment with oxaliplatin and an EGFR-inhibitor
F Hoffmann-La Roche    1755622*
 Treatment of lung diseases and pre-lung disease conditions
Transave    1755623*
 Polycation antimicrobial therapeutic
Neosil    1755624*
 Compsns and methods using same for treating neurodegenerative disorders
Future Products Management    1755625*
 Uses of bispecific antibody (Biab) coated dentritic cells pulsed with antigens
The Board of Trustees of the University of Illinois    1755626*
 Extracts of latex of Calotropis procera, and to a method of preparation thereof
All India Institute of Medical Sciences; International Centre for Genetic Engineering and Biotechology    1755627*
 Lactic bacteria and their use in the prevention of diarrhoea
Bio-K Plus International    1755628*
 Gingko biloba extract and method for producing the same
Goetech    1755629*
 Pharmaceutical compsns from beard lichen (Usnea barbata) and St John's Wort (Hypericum perforatum) and their use
Universitaetsklinikum Freiburg    1755630*
 Immunomodulation by a therapeutic medication intended for treatment of diabetes and prevention of autoimmune diabetes
Diamyd Medical    1755631*
 Sensitisation to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer therapy
Telik    1755632*
 Oral delivery of peptide pharmaceutical compsns
Unigene Laboratories    1755633*
 Oligopeptides for reducing elevated blood urea concentration
Biotempt    1755634*
 Treatment of inflammatory airway disease
GroPep    1755635*
 Sustained release compsn
Smart Drug Systems    1755636*
 Methods for preventing or treating bone disorders
Metabolic Pharmaceuticals    1755637*
 Multiple agent therapy for sexual dysfunction
Palatin Technologies    1755638*
 Epitopes related to coeliac disease
BTG International    1755639*
 Hybrid recombinases for genome manipulation
Poetic Genetics    1755640*
 Agonists and antagonists of P28, EB13 and WSX/TCCR for treating immune disorders
Schering    1755641*
 Annexin V for preventing atherothrombose and plaque rupture
Athera Biotechnologies    1755642*
 Compsns and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
Enzo Therapeutics; Li, Xiaofeng; Liu, Peng; Liu, Wenzhong; Engelhardt, Dean    1755643*
 Compsns comprising ADDL receptor syngap
Northwestern University    1755644*
 VEGF inhibitors for the treatment of malignant pleural effusion
Regeneron Pharmaceuticals; Memorial Sloan-Kettering Cancer Centre    1755645*
 Vascular targets for detecting, imaging and treating neoplasia or neovasculature
Sidney Kimmel Cancer Centre    1755646*
 Treatment of amyotrophic lateral sclerosis
VIB; D Collen Research Foundation    1755647*
 Cerberus/Coco derivatives and uses thereof
Acceleron Pharma    1755648*